These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3159798)

  • 21. Lymphocyte subsets and surface molecules in man.
    Krensky AM; Lanier LL; Engleman EG
    Clin Immunol Rev; 1985; 4(1):95-138. PubMed ID: 2992859
    [No Abstract]   [Full Text] [Related]  

  • 22. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.
    Singer A; Kruisbeek AM; Andrysiak PM
    J Immunol; 1984 May; 132(5):2199-209. PubMed ID: 6201534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection of thymocyte MHC restriction specificity in vitro.
    Rock KL; Yeh ET; Benacerraf B
    J Mol Cell Immunol; 1984; 1(5):311-20. PubMed ID: 6242861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats.
    Scherer MN; Graeb C; Tange S; Dyson C; Jauch KW; Geissler EK
    Hepatology; 2000 Nov; 32(5):999-1007. PubMed ID: 11050050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo generation, enhancement and recruitment of host cellular immune responses against tumor: influence of MHC antigen expression on clones of tumor cell variants.
    Fernández-Cruz E; Pérez M; Zabay JM; Garrido F
    Prog Clin Biol Res; 1987; 244():115-25. PubMed ID: 2958867
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.
    Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; Chames P; Hoogenboom HR; Reiter Y
    Cancer Res; 2002 Jun; 62(11):3184-94. PubMed ID: 12036932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relations between Ia antigens and the products of Ir genes. A theory of the evolution of the immune response].
    Seignalet J
    Pathol Biol (Paris); 1983 Jan; 31(1):53-9. PubMed ID: 6222280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Killing of rat adenocarcinoma 13762 in situ by adoptive transfer of CD4+ anti-tumor T cells requires tumor expression of cell surface MHC class II molecules.
    Frey AB; Cestari S
    Cell Immunol; 1997 May; 178(1):79-90. PubMed ID: 9184701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T cell regulation of B cell activation: MHC-restricted T augmenting cells enhance the B cell responses mediated by MHC-restricted cloned T helper cells.
    Asano Y; Hodes RJ
    J Immunol; 1984 Mar; 132(3):1151-7. PubMed ID: 6198379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parasite antigen-specific human T cell lines and clones. Major histocompatibility complex restriction and B cell helper function.
    Nutman TB; Ottesen EA; Fauci AS; Volkman DJ
    J Clin Invest; 1984 Jun; 73(6):1754-62. PubMed ID: 6233302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bifunctional T cell clones challenge the traditional compartmentalization concept of the immune system.
    Naor D
    Arch Immunol Ther Exp (Warsz); 1992; 40(1):67-70. PubMed ID: 1485830
    [No Abstract]   [Full Text] [Related]  

  • 33. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retroviral antibody binding of the MHC class II molecule: a biochemical influence on CD4 T cell differentiation in HIV infection?
    Powell PD; Demartini JC
    J Theor Biol; 2001 Mar; 209(2):155-60. PubMed ID: 11401457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of antigen-specific suppressor T lymphocytes in man involves dual recognition of self class I MHC molecules and Leu-4/T3-associated structures on the surface of inducer T lymphocytes.
    Damle NK; Mohagheghpour N; Engleman EG
    J Immunol; 1984 Sep; 133(3):1235-40. PubMed ID: 6205073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T lymphocyte culture established by repeated stimulation with the autologous lymphoblastoid line. MHC class II restricted interactions with B blasts.
    Torsteinsdottir S; Masucci MG; Szigeti R; Bishara A; Brautbar C; Klein G; Klein E
    Mol Biol Med; 1984 Aug; 2(4):285-99. PubMed ID: 6443579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the induction and expression of T cell-mediated immunity. XV. Role of non-MHC papain-sensitive target structures and Lyt-2 antigens in allogeneic and xenogeneic lectin-dependent cellular cytotoxicity (LDCC).
    Bonavida B; Katz J
    J Immunol; 1985 Sep; 135(3):1616-23. PubMed ID: 3874903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell interactions in antibody formation.
    Bell RG
    J Am Vet Med Assoc; 1982 Nov; 181(10):1011-14. PubMed ID: 6184351
    [No Abstract]   [Full Text] [Related]  

  • 39. The regulation of expression of histocompatibility antigens on the cell surface; molecular genetic basis.
    Petrányi GG
    Folia Biol (Praha); 1995; 41(3-4):163-77. PubMed ID: 7589712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine-induced activation status.
    Ritter M; Huber C; Auböck J; Pohl-Markl H; Troppmair J; Herold M; Gächter A; Nussbaumer W; Böck G; Nachbaur D
    Immunology; 1994 Apr; 81(4):569-77. PubMed ID: 7913694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.